Endo International (ENDP -8.6%) subsidiaries Endo Pharmaceuticals, Endo Health Solutions, Par Pharmaceutical and Par Pharmaceutical Companies have inked an agreement with two Ohio counties and certain related parties to settle their opioid epidemic-related litigation.
Under the terms of the settlement, Endo will pay $10M in cash to the plaintiffs and provide up to $1M of Vasostrict and/or Adrenalin to the counties at no charge without an admission of wrongdoing.
The company announced the settlement in principle on August 20.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.